Drug Utilization Analysis in Stroke Patients at Cilacap Regional Public Hospital Using the ATC/DDD Method and DU 90%
DOI:
https://doi.org/10.35960/vm.v17i1.1353Keywords:
Stroke medications, ATC/DDD, DU 90%Abstract
Stroke is a serious medical condition in which the blood supply to the brain is disrupted, leading to the death of brain cells. The use of stroke medications aims to prevent and treat thromboembolism, and the increased use of stroke medications reflects the high global morbidity and mortality rates. This study aims to describe the utilization of drugs for stroke in patients treated at Cilacap Regional Public Hospital in 2022. The research method used was a descriptive study with a retrospective approach, referring to medical record data. A total of 167 samples were taken by purposive sampling, and the samples were evaluated using the ATC/DDD method and DU 90%. The results showed that the highest DDD/100 bed days value was for oral Acetylsalicylic Acid at 128124.19, and the lowest DDD/100 bed days value was for intravenous Phytomenadione at 6.73. The stroke medication included in the DU 90% was the ischemic stroke drug, oral Acetylsalicylic Acid, with a DU% value of 97.61%. The stroke medications in the 10% segment were the ischemic stroke drugs, namely oral Clopidogrel, oral Cilostazol, and oral Warfarin, as well as the hemorrhagic stroke drugs, intravenous Tranexamic Acid and intravenous Phytomenadione. The DDD per 100 bed days value for stroke medications exceeded the WHO's appropriateness criteria.
References
Ahmad, Amier, and Suzanne Oparil. 2017. “Hypertension in Women: Recent Advances and Lingering Questions.” Hypertension 70(1):19–26. doi: 10.1161/HYPERTENSIONAHA.117.08317.
Ahmed, Nehad J. 2020. “Age and Gender Differences in the Pattern of Antiplatelet Agents Prescribing.” Journal of Pharmaceutical Research International 32(13):87–91. doi: 10.9734/jpri/2020/v32i1330588.
Atsma, Femke, Marie Louise E. L. Bartelink, Diederick E. Grobbee, and Yvonne T. Van Der Schouw. 2006. “Postmenopausal Status and Early Menopause as Independent Risk Factors for Cardiovascular Disease: A Meta-Analysis.” Menopause 13(2):265–79. doi: 10.1097/01.gme.0000218683.97338.ea.
Fagan, S. C. & Hess, D. C. 2019. Pharmacotherapy: A Pathophysiologic Approach, Chapter 20: Stroke. Tenth Edit. New York: Mc Graw Hill Education.
Feigin, Valery L., Michael Brainin, Bo Norrving, Sheila Martins, Ralph L. Sacco, Werner Hacke, Marc Fisher, Jeyaraj Pandian, and Patrice Lindsay. 2022. “World Stroke Organization (WSO): Global Stroke Fact Sheet 2022.” International Journal of Stroke 17(1):18–29. doi: 10.1177/17474930211065917.
Geoffrey D Barnes, MD, MSc, Eleanor Lucas, BA, G Caleb Alexander, MD, MS, And Zachary D. Goldberger, MD, MS. 2017. “National Trends in Ambulatory Oral Anticoagulant Use.” Physiology & Behavior 176(3):139–48. doi: 10.1053/j.gastro.2016.08.014.CagY.
Jiang, Minghuan, Pengchao Li, Joyce Hoi-Sze You, Xinglong Zheng, Jizhao Deng, Mingyue Zhao, Liuxin Feng, and Yu Fang. 2019. “Cost-Effectiveness Analysis of Aspirin for Primary Prevention of Cardiovascular Events among Patients with Type 2 Diabetes in China.” PLoS ONE 14(12):1–13. doi: 10.1371/journal.pone.0224580.
Kemenkes RI. 2018. “Stroke Dont Be The One.” Kemenkes RI. Retrieved (https://www.google.com/url?sa=t&source=web&rct=j&url=https://pusdatin.kemkes.go.id /download.php%3Ffile%3Ddownload/pusdatin/infodatin/infodatin-stroke-dont-be-the-%0Aone.pdf&ved=2ahUKEwiA65m1sLb0AhUP73MBHfYtBhYQFnoECAsQAQ&usg=AOvVaw2QP%0AHiPOGpQxmbHrI-HGP).
Kirchhof et al. 2016. “ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS.” European Heart Journal 37(38). doi: 10.1093/eurheartj/ehw210.
Kirley, Kate, Dima M. Qato, Rachel Kornfield, Randall S. Stafford, and G. Caleb Alexander. 2012. “National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011.” Circulation: Cardiovascular Quality and Outcomes 5(5):615–21. doi: 10.1161/CIRCOUTCOMES.112.967299.
Mahmudah et al, 2016. 2016. “Study of the Use of Antibiotics with ATC/DDD System and DU 90% in Digestive Surgery in Hospital in Bandung.” Indonesian Journal of Clinical Pharmacy 5(4):293–98. doi: 10.15416/ijcp.2016.5.4.293.
Manan, Mohamed Mansor, Aswani Yanti Baharuddin, Qi Ying Lean, Jagjit Singh Dhaliwal, Sachinjeet Kaur Sodhi Dhaliwal, Muhammed Junaid Farrukh, Ching Siang Tan, and Long Chiau Ming. 2022. “Comparison of the Factors That Influence the Pattern of Procurement and Usage of Antithrombotic Drugs.” Progress in Microbes and Molecular Biology 5(1):1–19. doi: 10.36877/pmmb.a0000283.
Meschia et al. 2014. Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals. Vol. 45.
Di Nisio, Marcello, Nick van Es, and Harry R. Büller. 2016. “Deep Vein Thrombosis and Pulmonary Embolism.” The Lancet 388(10063):3060–73. doi: 10.1016/S0140-6736(16)30514-1.
Pinzon, R., & Asanti, L. 2010. Awas Stroke! (Pengertian, Gejala, Tindakan, Perawatan, Dan Pencegahan). Yogyakarta: Andi Offset.
Rothwell, Peter M., Ale Algra, Zhengming Chen, Hans Christoph Diener, Bo Norrving, and Ziyah Mehta. 2016. “Effects of Aspirin on Risk and Severity of Early Recurrent Stroke after Transient Ischaemic Attack and Ischaemic Stroke: Time-Course Analysis of Randomised Trials.” The Lancet 388(10042):365–75. doi: 10.1016/S0140-6736(16)30468-8.
Sokolov A. V., and Reshetko O. V. 2021. “Analisis Volume Konsumsi Obat Antitrombotik Yang Digunakan Untuk Farmakoterapi Fibrilasi Atrium Di Wilayah Saratov.” 14(4).
Sunarti, Peppy octaviani. 2020. “The Effect of Antihypertensive of Tali ’ s Bamboo Shoot Ethanol Extract ( Gigantochloa Apus.” 20(Icch 2019):178–81.
Sutin, Uten, Srimuang Paluangrit, Supika Dangkrajang, Wandee Sutthinarakorn, and Vanida Prasert. 2022. “Problems and Needs When Caring for Stroke Patient at Homes.” International Journal of Public Health Science 11(2):695–705. doi: 10.11591/ijphs.v11i2.21013.
Welten, Sabrina J. G. C., N. Charlotte Onland-Moret, Jolanda M. A. Boer, W. M. Moniqu. Verschuren, and Yvonne T. Van Der Schouw. 2021. “Age at Menopause and Risk of Ischemic and Hemorrhagic Stroke.” Stroke (August):2583–91. doi: 10.1161/STROKEAHA.120.030558.
WHO. 2013. Guidlines for ATC Classification and DDD Assignment. 16 th. Nydalen : Norwegia Institute of Public Health: WHO.
WHO. 2015. Guidelines for ATC Classification and DDD Assignment. Norway: Norwegian Institute of Public Health.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Argi Asih, Sunarti, Khamdiyah Indah Kurniasih
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitted paper will be firstly reviewed by the editors to determine whether the paper meet the edition theme and submission guidelines. Papers which meet the theme and the guidelines will be assigned to selected reviewers for peer-reviews. Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan is a double blind peer-reviewed journal which involves reviewers based on their experties relevant to the topic of the paper. Final decision of paper acceptance is solely decided by the editors according to reviewers' comment.
Plagiarism and self-plagiarism are prohibited. Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan uses PlagiarismCheckerX and iThenticate to scan papers for detecting plagiarism. Thus, Appropriate citation and quotation should be used
.png)
.png){kind=small}
